financetom
Business
financetom
/
Business
/
Align Technology Q1 Non-GAAP Earnings, Revenue Rise; Q2 Revenue Guidance, Stock Buyback Set; Shares Rise After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Align Technology Q1 Non-GAAP Earnings, Revenue Rise; Q2 Revenue Guidance, Stock Buyback Set; Shares Rise After Hours
Apr 24, 2024 1:43 PM

04:27 PM EDT, 04/24/2024 (MT Newswires) -- Align Technology ( ALGN ) reported Q1 non-GAAP earnings late Wednesday of $2.14 per diluted share, up from $1.82 a year earlier.

Analysts polled by Capital IQ expected $1.97.

Revenue in the quarter ended March 31 rose to $997.4 million from $943.1 million a year earlier. Analysts surveyed by Capital IQ expected $973.8 million.

In Q2, the company expects revenue to be $1.03 billion to $1.05 billion. Analysts in a Capital IQ poll expect $1.03 billion.

In 2024, the company projects revenue growth of 6% to 8% from a year earlier. Analysts in a Capital IQ survey expect $4.05 billion.

The company expects to repurchase up to $150 million of common stock through open market repurchases or an accelerated stock repurchase agreement.

Shares of the company climbed 5.9% in after-hours activity.

Price: 332.40, Change: +18.62, Percent Change: +5.93

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Corbus Pharma Q3 net loss widens to $23.3 mln
Corbus Pharma Q3 net loss widens to $23.3 mln
Nov 12, 2025
Overview * Corbus Pharmaceuticals ( CRBP ) Q3 net loss widens to $23.3 mln, driven by clinical development costs * Company completed $75 mln public offering, extending cash runway into 2028 * CRB-701 clinical data shows promising ORR in HNSCC, cervical, and bladder cancers Outlook * Company plans to meet FDA in Q1 2026 for CRB-701 data review * Corbus...
Apparel retailer LightInTheBox Q3 net income jumps, revenue drops on margin focus
Apparel retailer LightInTheBox Q3 net income jumps, revenue drops on margin focus
Nov 12, 2025
Overview * LightInTheBox ( LITB ) Q3 net income rises to $2.8 mln from $0.3 mln last year * Company Q3 revenue declines 3% yr/yr, reflecting focus on margin preservation * Gross margin improves to 66.9% from 61.1% last year, driven by high-margin products Outlook * LightInTheBox ( LITB ) expects overall revenue growth in 2026 * Company plans broader...
Coya Therapeutics' Q3 net loss narrows
Coya Therapeutics' Q3 net loss narrows
Nov 12, 2025
Overview * Coya Therapeutics ( COYA ) Q3 net loss narrows to $2.1 mln from $4.0 mln last year * Company reports $3.6 mln collaboration revenue due to IND approval milestone * Coya completes $23 mln public offering, extending cash runway into 2H 2027 Outlook * Company expects to receive $4.2 mln milestone payment upon first patient dosing in ALS...
Cypherpunk Technologies' Q3 net loss narrows
Cypherpunk Technologies' Q3 net loss narrows
Nov 12, 2025
Overview * Cypherpunk Technologies reports Q3 net loss of $3.3 mln, down from $18.2 mln last year * Company acquires 203,775 ZEC for $50 mln as part of digital asset strategy * Closed $58.88 mln private placement led by Winklevoss Capital for digital asset strategy Outlook * Company did not provide specific financial guidance for future quarters or year Result...
Copyright 2023-2026 - www.financetom.com All Rights Reserved